PTK2 and acute promyelocytic leukemia: Thirdly, although technologies like CRISPR-Cas9 have been widely used in malignant tumor research, more gene editing methods should be employed in future explorations of the regulatory roles of LDH and PTK2 genes to delve deeper into their molecular mechanisms in APL.